Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
BRCA
Breast cancer
fertility preservation
pregnancy
young patients
Journal
Breast cancer : basic and clinical research
ISSN: 1178-2234
Titre abrégé: Breast Cancer (Auckl)
Pays: United States
ID NLM: 101474356
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
07
2020
accepted:
10
08
2020
entrez:
21
9
2020
pubmed:
22
9
2020
medline:
22
9
2020
Statut:
epublish
Résumé
The improved prognosis of breast cancer patients makes survivorship issues an area of crucial importance. In this regard, an increased attention is needed toward the development of potential anticancer treatment-related long-term side-effects, including gonadal failure and infertility in young women. Therefore, fertility preservation and family planning are crucial issues to be addressed in all young women of reproductive age with newly diagnosed cancer. Despite a growing availability of data on the efficacy and safety of fertility preservation options and the fact that conceiving after prior history of breast cancer has become more accepted over time, there are still several gray zones in this field so that many physicians remain uncomfortable to deal with these topics. The purpose of this review is to answer some of the most controversial questions frequently asked by patients during their oncofertility counseling, in order to provide a detailed and up-to-date overview on the evidence available in this field to physicians involved in the care of young women with breast cancer.
Identifiants
pubmed: 32952399
doi: 10.1177/1178223420954179
pii: 10.1177_1178223420954179
pmc: PMC7476336
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1178223420954179Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests:The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Matteo Lambertini acted as a consultant for Roche and Novartis, and received honoraria from Theramex, Takeda, Roche, Lilly, Pfizer and Novartis outside the submitted work. All remaining authors declare no conflict of interest.
Références
Breast Cancer Res Treat. 2019 May;175(1):17-25
pubmed: 30707336
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
Ann Oncol. 2016 Feb;27(2):357
pubmed: 26609009
Clin Med Insights Reprod Health. 2019 Dec 3;13:1179558119884945
pubmed: 31839716
Clin Med Insights Reprod Health. 2019 Aug 21;13:1179558119870163
pubmed: 31488958
J Clin Oncol. 2016 May 10;34(14):1689-701
pubmed: 26884586
Fertil Steril. 2013 May;99(6):1514-22
pubmed: 23541406
J Clin Oncol. 2017 Mar;35(7):804-805
pubmed: 27893335
Cancer Treat Rev. 2017 Jun;57:50-57
pubmed: 28550713
J Clin Oncol. 2014 Jul 20;32(21):2255-69
pubmed: 24868023
Fertil Steril. 2018 Feb;109(2):349-355
pubmed: 29338854
Ann Oncol. 2017 Aug 1;28(8):1683-1685
pubmed: 28838207
Curr Opin Oncol. 2017 Jul;29(4):243-252
pubmed: 28463857
Ann Oncol. 2013 Oct;24 Suppl 6:vi160-70
pubmed: 23813932
Fertil Steril. 2013 Jan;99(1):37-43
pubmed: 23083924
Ann Oncol. 2018 Jul 1;29(7):1497-1508
pubmed: 29873695
Breast Cancer Res Treat. 2018 Apr;168(3):773-774
pubmed: 29335923
BMJ. 2007 Jan 27;334(7586):194
pubmed: 17158581
Clin Med Insights Reprod Health. 2019 Mar 09;13:1179558119828393
pubmed: 30886529
J Clin Oncol. 2018 Jul 1;36(19):1895-1897
pubmed: 29718789
Psychooncology. 2014 Feb;23(2):173-82
pubmed: 24038775
J Clin Oncol. 2016 Sep 20;34(27):3308-14
pubmed: 27480155
Fertil Steril. 2018 Mar;109(3):478-485.e2
pubmed: 29428307
Fertil Steril. 2013 Nov;100(5):1214-23
pubmed: 24011612
Hum Reprod Update. 2019 Nov 5;25(6):673-693
pubmed: 31600388
Fertil Steril. 2019 Feb;111(2):363-371
pubmed: 30527950
Breast Cancer Res. 2014 Aug 27;16(4):427
pubmed: 25436920
Hum Reprod Update. 2020 Jan 1;26(1):43-57
pubmed: 31822904
Lancet Oncol. 2017 Dec;18(12):1579-1589
pubmed: 29111259
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
J Clin Oncol. 2020 Apr 20;38(12):1258-1267
pubmed: 31618128
BMC Med. 2016 Jan 04;14:1
pubmed: 26728489
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
Curr Opin Oncol. 2019 May;31(3):247-255
pubmed: 30789866
Breast Cancer Res Treat. 2014 May;145(1):113-28
pubmed: 24671358
Cell Cycle. 2014;13(17):2674-80
pubmed: 25486355
J Natl Cancer Inst. 2017 May 1;109(5):
pubmed: 28376233
J Natl Cancer Inst. 2018 Apr 01;110(4):426-429
pubmed: 29087485
Br J Cancer. 2016 Dec 6;115(12):1471-1478
pubmed: 27802449
Breast J. 2010 Jul-Aug;16(4):404-11
pubmed: 20522097
J Assist Reprod Genet. 2016 Aug;33(8):971-80
pubmed: 27146151
Breast Cancer Res Treat. 2020 Aug;183(1):239-240
pubmed: 32596767
Sci Transl Med. 2013 Feb 13;5(172):172ra21
pubmed: 23408054
Fertil Steril. 2017 Jan;107(1):243-252.e5
pubmed: 27887709
J Clin Oncol. 2013 Nov 1;31(31):3914-9
pubmed: 23980083
Eur J Cancer. 2017 Jan;71:25-33
pubmed: 27940355
Cancer. 2019 Jan 15;125(2):307-316
pubmed: 30335191
Rev Invest Clin. 2017 Mar-Apr;69(2):103-113
pubmed: 28453508
Ann Oncol. 2015 Dec;26(12):2408-19
pubmed: 26347105
Hum Reprod. 2018 Jul 1;33(7):1281-1290
pubmed: 29912328
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Clin Oncol. 2015 Aug 1;33(22):2424-9
pubmed: 26101247
Gynecol Endocrinol. 2015 Jun;31(6):458-64
pubmed: 25982361
Cancer. 2018 Nov 15;124(22):4401-4407
pubmed: 30403424
Cancer Treat Rev. 2019 Jan;72:65-77
pubmed: 30530271
Breast. 2018 Oct;41:51-56
pubmed: 30007268
J Clin Oncol. 2011 Jun 10;29(17):2334-41
pubmed: 21537042
Ann Oncol. 2019 Oct 1;30(10):1541-1557
pubmed: 31373601
Front Endocrinol (Lausanne). 2018 Jun 28;9:347
pubmed: 30002647
Cancer. 2012 Mar 15;118(6):1710-7
pubmed: 21887678
Breast Cancer Res Treat. 2019 Feb;174(1):27-37
pubmed: 30465156
Clin Med Insights Reprod Health. 2019 Jul 31;13:1179558119864584
pubmed: 31391786
Int J Mol Sci. 2019 Nov 30;20(23):
pubmed: 31801245
J Clin Oncol. 2019 Feb 10;37(5):423-438
pubmed: 30452337
Int J Cancer. 2011 Sep 1;129(5):1225-36
pubmed: 21387311
J Clin Oncol. 2016 Aug 1;34(22):2563-5
pubmed: 27217452
Fertil Steril. 2014 Aug;102(2):488-495.e3
pubmed: 24934489
Hum Reprod. 2019 Aug 1;34(8):1462-1469
pubmed: 31339999
J Clin Oncol. 2005 Jun 1;23(16):3858-9
pubmed: 15911867
Ann Oncol. 2018 Jan 1;29(1):237-243
pubmed: 29045555
Breast Cancer Res Treat. 2017 Aug;165(1):151-159
pubmed: 28503722
Hum Reprod. 2015 Dec;30(12):2926-35
pubmed: 26466914
Reprod Biomed Online. 2019 May;38(5):835-844
pubmed: 30914152
Breast. 2015 Jun;24(3):201-7
pubmed: 25662412
J Clin Oncol. 2005 Jul 1;23(19):4347-53
pubmed: 15824416
J Natl Cancer Inst. 2019 Jan 1;111(1):86-94
pubmed: 29878225
Mol Hum Reprod. 2014 Oct;20(10):948-59
pubmed: 25080441
Breast Cancer Res Treat. 2016 Nov;160(2):347-360
pubmed: 27683280
J Clin Oncol. 2018 Jul 1;36(19):1981-1990
pubmed: 29718793
Cancer Treat Rev. 2017 Sep;59:61-70
pubmed: 28750297
Breast Cancer Res Treat. 2018 Feb;167(3):761-769
pubmed: 29098528
Fertil Steril. 2015 Nov;104(5):1162-7
pubmed: 26335130
Breast. 2017 Oct;35:203-217
pubmed: 28822332
J Gynecol Obstet Hum Reprod. 2018 Oct;47(8):351-357
pubmed: 29793036
Ther Adv Med Oncol. 2019 Feb 25;11:1758835919827714
pubmed: 30833989
Hum Reprod. 2017 Oct 1;32(10):2123-2129
pubmed: 28938748
Breast Cancer Res Treat. 2018 Aug;171(1):245-246
pubmed: 29744675
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259161
J Clin Oncol. 2014 Apr 10;32(11):1151-6
pubmed: 24567428
J Clin Endocrinol Metab. 2016 Apr;101(4):1364-71
pubmed: 26751194
JAMA Oncol. 2017 May 1;3(5):659-665
pubmed: 28278319
Lancet Oncol. 2014 Sep;15(10):1129-36
pubmed: 25130994
J Clin Oncol. 2012 Feb 10;30(5):533-8
pubmed: 22231041
JAMA. 2015 Dec 22-29;314(24):2632-40
pubmed: 26720025
Reprod Biomed Online. 2011 Feb;22(2):162-71
pubmed: 21239230
J Clin Oncol. 2020 Sep 10;38(26):3012-3023
pubmed: 32673153
Front Oncol. 2019 Jul 12;9:575
pubmed: 31355134
Ann Oncol. 2017 Aug 1;28(8):1811-1816
pubmed: 28472240
Oncologist. 2015 Nov;20(11):1233-5
pubmed: 26463868
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
J Clin Oncol. 2006 Jun 20;24(18):2917-31
pubmed: 16651642
Cancer. 2020 Feb 1;126(3):487-495
pubmed: 31639215
J Assist Reprod Genet. 2018 Apr;35(4):561-570
pubmed: 29497953
J Am Coll Surg. 2009 Nov;209(5):603-7
pubmed: 19854400
J Natl Cancer Inst. 2019 Feb 1;111(2):210-213
pubmed: 30371800
J Natl Cancer Inst. 2018 Aug 1;110(8):919-920
pubmed: 29329404
Lancet Oncol. 2018 Feb;19(2):169-180
pubmed: 29337092
Contemp Oncol (Pozn). 2017;21(4):290-294
pubmed: 29416435
Breast Care (Basel). 2020 Apr;15(2):148-156
pubmed: 32398983
Breast. 2018 Dec;42:41-49
pubmed: 30170202
Future Oncol. 2016 Oct;12(20):2333-44
pubmed: 27402553